Association Between Coffee Consumption with Serum Lipid Profile in ELSA-Brasil Study: a Metabolomic Approach
Overview
Authors
Affiliations
Purpose: This study evaluated the association between coffee consumption and serum lipid profile in the Brazilian Longitudinal Study of Adult Health (ELSA-Brasil).
Methods: This is a cross-sectional study on baseline data from participants of the cohort ELSA-Brasil. Only participants of São Paulo Research Center who underwent a nuclear magnetic resonance (NMR) spectroscopy examination of lipid profile were included (N = 4736). Coffee intake was categorized into four categories (cups/day, in reference cup size of 50 mL, which is the household measure adopted in Brazil): never/almost never, ≤ 1, 1-3, and > 3. Serum lipid profile [i.e., Total Cholesterol (TC), Total Triglycerides (TG), Very Low-Density Lipoprotein-cholesterol (VLDL-c), Low-Density Lipoprotein-cholesterol (LDL-c), High-Density Lipoprotein-cholesterol (HDL-c), Triglyceride-rich Lipoprotein Particles (TRLP) and subfractions particles] was analyzed. To estimate the effect of coffee consumption on serum lipid profile, multivariate Generalized Linear Models were performed.
Results: Compared to participants who never or almost never drink coffee, individuals who consumed more than 3 cups/day showed an increase in concentrations of TC (β: 4.13; 95% CI 0.81, 7.45), TG (β: 9.53; 95% CI 1.65, 17.42), VLDL-c (β: 1.90; 95% CI 0.38, 3.42), TRLP (β: 8.42; 95% CI 1.24, 15.60), and Very Small-TRLP and Medium-TRLP subfractions (β: 7.36; 95% CI 0.21, 14.51; β: 2.53; 95% CI 0.89, 4.16, respectively), but not with HDL-c and LDL-c. Among individuals with low (≤ 1 cup/day) and moderate (1-3 cups/day) coffee consumption, no significant associations with lipids was observed.
Conclusion: High coffee consumption (more than 3 cups per day) was associated with an increase in serum lipids, namely TC, TG, VLDL-c, and TRL particles, highlighting the importance of a moderate consumption of this beverage.
Coffee: Fuel for Your Day or Foe for Your Arteries.
Buelna-Chontal M Antioxidants (Basel). 2025; 13(12.
PMID: 39765784 PMC: 11672806. DOI: 10.3390/antiox13121455.
Daneshvar-Ghahfarokhi S, Ayoobi F, Ahmadinia H, Vazirinejad R, Mohammadi-Shahrokhi V Sci Rep. 2024; 14(1):28461.
PMID: 39557974 PMC: 11574096. DOI: 10.1038/s41598-024-79929-4.
Associations of urinary caffeine and caffeine metabolites with metabolic syndrome in US adults.
Zhou J, Qin L Front Nutr. 2023; 10:1280215.
PMID: 38107745 PMC: 10722267. DOI: 10.3389/fnut.2023.1280215.